Search results
Results from the WOW.Com Content Network
Alcohol dependence is a previous (DSM-IV and ICD-10) psychiatric diagnosis in which an individual is physically or psychologically dependent upon alcohol (also chemically known as ethanol). In 2013, it was reclassified as alcohol use disorder in DSM-5 , [ 1 ] which combined alcohol dependence and alcohol abuse into this diagnosis.
Psychoactive substance-induced psychotic disorders outlined within the ICD-10 codes F10.5—F19.5: F10.5 alcohol: [8] [9] [10] Alcohol is a common cause of psychotic disorders or episodes, which may occur through acute intoxication, chronic alcoholism, withdrawal, exacerbation of existing disorders, or acute idiosyncratic reactions. [8]
291.1 Alcohol-induced persisting amnestic disorder; 291.x Alcohol-induced psychotic disorder.5 With delusions.3 With hallucinations; 291.89 Alcohol-induced mood disorder (coded 291.8 in the DSM-IV) 291.89 Alcohol-induced anxiety disorder (coded 291.8 in the DSM-IV) 291.89 Alcohol-induced sexual dysfunction (coded 291.8 in the DSM-IV)
But levels of GGT are elevated in only half of men with alcohol use disorder, and it is less commonly elevated in women and younger people. [134] GGT levels remain persistently elevated for many weeks with continued drinking, with a half life of 2-3 weeks, making the GGT level a useful assessment of continued and chronic alcohol use. [134]
Alcohol-induced mood disorder: Coded 291.8 in the DSM-IV. 291.1: Alcohol-induced persisting amnestic disorder: 291.2: Alcohol-induced persisting dementia: 291.x: Alcohol-induced psychotic disorder: 291.5: Alcohol-induced psychotic disorder, with delusions: 291.3: Alcohol-induced psychotic disorder, with hallucinations: 291.89: Alcohol-induced ...
Examples (and ICD-10 code) of withdrawal syndrome include: F10.3 alcohol withdrawal syndrome (which can lead to delirium tremens) F11.3 Opioid withdrawal, including methadone withdrawal [9] F12.3 cannabis withdrawal; F13.3 benzodiazepine withdrawal; F14.3 cocaine withdrawal; F15.3 caffeine withdrawal; F17.3 nicotine withdrawal
Marchiafava–Bignami disease (MBD) is a progressive neurological disease of alcohol use disorder, characterized by corpus callosum demyelination and necrosis and subsequent atrophy. The disease was first described in 1903 by the Italian pathologists Amico Bignami and Ettore Marchiafava in an Italian Chianti drinker.
The DSM-5 (2013), the current version, also features ICD-9-CM codes, listing them alongside the codes of Chapter V of the ICD-10-CM. On 1 October 2015, the United States health care system officially switched from the ICD-9-CM to the ICD-10-CM. [1] [2] The DSM is the authoritative reference work in diagnosing mental disorders in the world.